Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Medical practitioners join forces to help students studying medicine with loans
2010-02-24

Medical practitioners from the University of the Free State’s Faculty of Health Sciences have established a loan fund for enrolled students studying medicine to assist them with their studies. This loan fund has paid out a total amount of R329 106,00 over the past three years.

During 2002 the faculty’s School of Medicine identified a gap in the awarding of bursaries to enrolled students studying medicine at the UFS.

Many students who follow the course M.B.Ch.B struggle to obtain bursaries and are often forced to cease their studies due to a lack of funds.

A group of medical practitioners addressed this gap by providing funds in the form of voluntary out-of-pocket contributions towards a study loan fund to deserving students. This fund has received over R1million in contributions over the years.

Although the loans do not cover the full costs of a particular student, it brings the necessary financial relief and enables the student to focus on his/her studies and at least register. It also gives the student the time at the beginning of the year to attain more money to study.

The loan is repayable as soon as the student is employed. Repayment is calculated on the income of the individual and is administrated by an outside organisation at a minimal interest rate that only kicks in when the loan becomes repayable.

The School of Medicine encourages students who qualify for this loan to seek alternative funding. In this way, more students can be supported annually.

Currently an average of eight to twelve students per year are helped from this loan fund.

Media Release
Issued by: Lacea Loader
Director: Strategic Communication (actg)
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl@ufs.ac.za  
24 February 2010

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept